Updated Recommendation
A new evidence synthesis was published:2018, Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
View latest version (2018)Bibliographic Info
Recommendation
Recommended in favor
Conditional
Certainty of evidence
Very low
lopinavir/r or atazanavir/r (ATV/r) is recommended as the preferred third drug for HIV post-exposure prophylaxis for adults and adolescents. Where available, RAL, darunavir/r (DRV/r) or efavirenz (EFV) can be considered as alternative options.
Also Featured In
This recommendation also appears in the following guidelines:
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection